{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:07:46Z","timestamp":1795187266842,"version":"4.10.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/aims<\/jats:title>\n                <jats:p>Having type 2 diabetes (T2D) in combination with being overweight results in an additional increase in cardiovascular disease (CVD) risk. In addition, T2D and obesity are associated with increased levels of total homocysteine (tHcy), possibly contributing to the CVD risk. Weight loss dieting has positive effects on several CVD risk factors, but whether it affects tHcy remains unclear. Therefore, the aim of this study was to determine the effect of a calorie restricted diet on tHcy in overweight people with T2D.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this post-hoc analysis of the POWER study, adults with T2D and a BMI greater than 27\u00a0kg\/m\u00b2 were included from the outpatient diabetes clinic of the Erasmus Medical Center, Rotterdam. The patients were subjected to a very low-calorie diet with fortified meal replacements for 20 weeks. Before and after this intervention, blood samples were collected to measure tHcy and other CVD risk factors like glycaemic and lipid parameters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>161 overweight participants with T2D were included, with a mean age of 54 years (range 26\u201374), mean weight of 104.6\u2009\u00b1\u200919.9\u00a0kg and mean HbA1c of 62.7\u2009\u00b1\u200914.3 mmol\/mol. At baseline, men displayed higher tHcy than women, and tHcy level was positively correlated with body weight and triglyceride levels, while it was negatively correlated with renal function and HDL cholesterol. During the intervention, bodyweight was reduced by a mean of 9.7% (from 104.6\u2009\u00b1\u200919.9 to 94.5\u2009\u00b1\u200918.1\u00a0kg p\u2009&lt;\u20090.001), and all measured glycaemic and lipid blood parameters improved significantly. However, tHcy remained unchanged (from 12.1\u2009\u00b1\u20094.1 to 12.1\u2009\u00b1\u20094.2 umol\/L, p\u2009=\u20090.880). The change in tHcy during the intervention was negatively associated with the change in weight and BMI (p\u2009=\u20090.01 and p\u2009=\u20090.008, respectively). People who lost\u2009&lt;\u200910\u00a0kg (n\u2009=\u200992) had a mean tHcy change of -0.47 umol\/L, while people who lost more than \u2265\u200910\u00a0kg (n\u2009=\u200969) had a mean tHcy change of 0.60 umol\/L (p\u2009=\u20090.021).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In conclusion, our data show that a calorie restricted diet does not affect tHcy in people with T2D and obesity, despite the use of meal replacements fortified with folic acid and vitamin B12. Our data showed a negative correlation between change in tHcy levels and weight loss, suggesting that people who lost more weight (&gt;\u200910\u00a0kg) showed an increase in tHcy. Future studies should explore the potential increase in tHcy induced by weight loss dieting and target the question if tHcy reduction strategies during weight loss could be clinically beneficial.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12937-023-00908-y","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T03:02:09Z","timestamp":1704250929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effect of diet-induced weight loss on circulating homocysteine levels in people with obesity and type 2 diabetes"],"prefix":"10.1186","volume":"23","author":[{"given":"Meryem","family":"Al Fatly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique T.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine","family":"Roeters van Lennep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk J.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten A.C.","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"issue":"2","key":"908_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.106.685628","volume":"116","author":"EL Barr","year":"2007","unstructured":"Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, et al. Risk of cardiovascular and all-cause mortality in individuals with Diabetes Mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, obesity, and Lifestyle Study (AusDiab). Circulation. 2007;116(2):151\u20137.","journal-title":"Circulation"},{"issue":"11","key":"908_CR2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","volume":"126","author":"ME Pich\u00e9","year":"2020","unstructured":"Pich\u00e9 ME, Tchernof A, Despr\u00e9s JP. Obesity phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res. 2020;126(11):1477\u2013500.","journal-title":"Circ Res"},{"issue":"2","key":"908_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S2213-8587(14)70229-3","volume":"3","author":"SA Grover","year":"2015","unstructured":"Grover SA, Kaouache M, Rempel P, Joseph L, Dawes M, Lau DC, et al. Years of life lost and healthy life-years lost from Diabetes and Cardiovascular Disease in overweight and obese people: a modelling study. Lancet Diabetes Endocrinol. 2015;3(2):114\u201322.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"908_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9150(01)00531-7","volume":"159","author":"MC Audelin","year":"2001","unstructured":"Audelin MC, Genest J. Jr. Homocysteine and Cardiovascular Disease in Diabetes Mellitus. Atherosclerosis. 2001;159(2):497\u2013511.","journal-title":"Atherosclerosis"},{"issue":"8","key":"908_CR5","first-page":"CD006612","volume":"8","author":"AJ Mart\u00ed-Carvajal","year":"2017","unstructured":"Mart\u00ed-Carvajal AJ, Sol\u00e0 I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8(8):CD006612.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"908_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12916-021-01977-8","volume":"19","author":"S Yuan","year":"2021","unstructured":"Yuan S, Mason AM, Carter P, Burgess S, Larsson SC. Homocysteine, B vitamins, and Cardiovascular Disease: a mendelian randomization study. BMC Med. 2021;19(1):97.","journal-title":"BMC Med"},{"key":"908_CR7","unstructured":"Cm P, Homocysteine. Cleveland Clinic; 2023 [updated 2023."},{"key":"908_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","volume":"49","author":"H Refsum","year":"1998","unstructured":"Refsum H, Ueland PM, Nyg\u00e5rd O, Vollset SE. Homocysteine and Cardiovascular Disease. Annu Rev Med. 1998;49:31\u201362.","journal-title":"Annu Rev Med"},{"issue":"Suppl 1","key":"908_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.dsx.2016.12.023","volume":"11","author":"MT Mursleen","year":"2017","unstructured":"Mursleen MT, Riaz S. Implication of homocysteine in Diabetes and impact of folate and vitamin B12 in diabetic population. Diabetes Metab Syndr. 2017;11(Suppl 1):141\u2013S6.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"908_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1365-2796.2005.01560.x","volume":"258","author":"SS Soedamah-Muthu","year":"2005","unstructured":"Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD, et al. Plasma homocysteine and microvascular and macrovascular Complications in type 1 Diabetes: a cross-sectional nested case-control study. J Intern Med. 2005;258(5):450\u20139.","journal-title":"J Intern Med"},{"key":"908_CR11","doi-asserted-by":"publisher","first-page":"2156483","DOI":"10.1155\/2022\/2156483","volume":"2022","author":"J Lu","year":"2022","unstructured":"Lu J, Chen K, Chen W, Liu C, Jiang X, Ma Z, et al. Association of Serum Homocysteine with Cardiovascular and all-cause mortality in adults with Diabetes: a prospective cohort study. Oxid Med Cell Longev. 2022;2022:2156483.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"908_CR12","doi-asserted-by":"publisher","first-page":"107834","DOI":"10.1016\/j.jdiacomp.2020.107834","volume":"35","author":"E Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107 E, Kraljevi\u0107 I, Solak M, Dragni\u0107 S, Mikhailidis DP. Homocysteine and Diabetes: role in macrovascular and microvascular Complications. J Diabetes Complications. 2021;35(3):107834.","journal-title":"J Diabetes Complications"},{"issue":"Supplement1","key":"908_CR13","first-page":"100","volume":"44","author":"A American Diabetes","year":"2020","unstructured":"American Diabetes A. 8. Obesity management for the treatment of type 2 Diabetes: standards of Medical Care in Diabetes\u20142021. Diabetes Care. 2020;44(Supplement1):100\u2013S10.","journal-title":"Diabetes Care"},{"issue":"1","key":"908_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/sj.ijo.0802529","volume":"28","author":"H Harder","year":"2004","unstructured":"Harder H, Dinesen B, Astrup A. The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. 2004;28(1):180\u20132.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"4","key":"908_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1464-5491.2003.00937.x","volume":"20","author":"P Dhindsa","year":"2003","unstructured":"Dhindsa P, Scott AR, Donnelly R. Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with type 2 Diabetes in secondary failure: outcomes after 1 year. Diabet Med. 2003;20(4):319\u201324.","journal-title":"Diabet Med"},{"issue":"11","key":"908_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","volume":"4","author":"ARG Look","year":"2016","unstructured":"Look ARG, Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term Cardiovascular Disease outcomes in overweight or obese people with type 2 Diabetes: a post-hoc analysis of the look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913\u201321.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9921","key":"908_CR17","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0140-6736(13)61836-X","volume":"383","author":"C Diseases","year":"2014","unstructured":"Global Burden of Metabolic Risk Factors for Chronic, Diseases C, Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary Heart Disease and Stroke: a pooled analysis of 97 prospective cohorts with 1\u00b78 million participants. Lancet. 2014;383(9921):970\u201383.","journal-title":"Lancet"},{"issue":"2","key":"908_CR18","first-page":"156","volume":"61","author":"RA Karatela","year":"2009","unstructured":"Karatela RA, Sainani GS. Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives. Indian Heart J. 2009;61(2):156\u20139.","journal-title":"Indian Heart J"},{"issue":"4","key":"908_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.15537\/smj.2019.4.24007","volume":"40","author":"O Persil-Ozkan","year":"2019","unstructured":"Persil-Ozkan O, Yigit E, Yigit Z. Does weight loss affect the parameters that are metabolically related to Cardiovascular Diseases? Saudi Med J. 2019;40(4):347\u201352.","journal-title":"Saudi Med J"},{"key":"908_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1186\/1471-2458-12-1026","volume":"12","author":"KA Berk","year":"2012","unstructured":"Berk KA, Buijks H, Ozcan B, Van\u2019t Spijker A, Busschbach JJ, Sijbrands EJ. The Prevention of WEight regain in Diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trial. BMC Public Health. 2012;12:1026.","journal-title":"BMC Public Health"},{"issue":"6","key":"908_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00125-017-4246-y","volume":"60","author":"KA Berk","year":"2017","unstructured":"Berk KA, Yahya R, Verhoeven AJM, Touw J, Leijten FP, van Rossum EF, et al. Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 Diabetes. Diabetologia. 2017;60(6):989\u201397.","journal-title":"Diabetologia"},{"issue":"1","key":"908_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.diabres.2012.05.027","volume":"98","author":"P Sudchada","year":"2012","unstructured":"Sudchada P, Saokaew S, Sridetch S, Incampa S, Jaiyen S, Khaithong W. Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 Diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2012;98(1):151\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"908_CR23","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/ajcn\/77.5.1318","volume":"77","author":"FV van Oort","year":"2003","unstructured":"van Oort FV, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB, et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. Am J Clin Nutr. 2003;77(5):1318\u201323.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"908_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1743-7075-8-64","volume":"8","author":"CE Metzner","year":"2011","unstructured":"Metzner CE, Folberth-V\u00f6gele A, Bitterlich N, Lemperle M, Sch\u00e4fer S, Alteheld B, et al. Effect of a conventional energy-restricted modified diet with or without meal replacement on weight loss and cardiometabolic risk profile in overweight women. Nutr Metab (Lond). 2011;8(1):64.","journal-title":"Nutr Metab (Lond)"},{"issue":"3","key":"908_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ijcard.2003.12.036","volume":"98","author":"DB Panagiotakos","year":"2005","unstructured":"Panagiotakos DB, Pitsavos C, Zeimbekis A, Chrysohoou C, Stefanadis C. The association between lifestyle-related factors and plasma homocysteine levels in healthy individuals from the ATTICA Study. Int J Cardiol. 2005;98(3):471\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2003.12.036.","journal-title":"Int J Cardiol"},{"issue":"8","key":"908_CR26","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2337\/dc12-1846","volume":"36","author":"A Tirosh","year":"2013","unstructured":"Tirosh A, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Rudich A, et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care. 2013;36(8):2225\u201332.","journal-title":"Diabetes Care"},{"issue":"7","key":"908_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3346\/jkms.2013.28.7.1015","volume":"28","author":"SB Park","year":"2013","unstructured":"Park SB, Georgiades A. Changes in body composition predict homocysteine changes and hyperhomocysteinemia in Korea. J Korean Med Sci. 2013;28(7):1015\u201320.","journal-title":"J Korean Med Sci"},{"key":"908_CR28","doi-asserted-by":"publisher","first-page":"A3","DOI":"10.1016\/j.jss.2019.10.049","volume":"259","author":"AD Althouse","year":"2021","unstructured":"Althouse AD. Post Hoc Power: not empowering, just misleading. J Surg Res. 2021;259:A3\u2013A6.","journal-title":"J Surg Res"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-023-00908-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12937-023-00908-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-023-00908-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T15:05:43Z","timestamp":1704294343000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-023-00908-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1186\/s12937-023-00908-y","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research has been approved by The Medical Ethics Committee of the Erasmus Medical Center of Rotterdam, the Netherlands, (reference number MEC-2009-143\/NL26508.078.09) in accordance with the Helsinki declaration. All participants have provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}